Kymera Therapeutics, Inc. (KYMR) vs Insulet Corp. (PODD)

A side-by-side comparison of Kymera Therapeutics, Inc. and Insulet Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — KYMR vs PODD

growth of $100 · dividends reinvested · last 6y
KYMR +230.3% (+22.0%/yr)PODD -35.3% (-7.0%/yr)KYMR compounded faster over this window
Log scale — wide-divergence pair
101001kStart $100202120222023202420252026$330$65
KYMR PODD

KYMR vs PODD: by the numbers

  • •PODD is the larger company ($9.38B vs $8.62B market cap).
  • •PODD is profitable (12.29% net margin) while KYMR runs a net loss (-285.41%).
  • •PODD grew revenue faster over the past five years (25.13% vs 10.22% CAGR).

Metrics side by side

Valuation

MetricKYMRPODD
P/E ratioN/A25.32
Forward P/EN/A20.83
PEG ratioN/A0.24
P/S ratio82.143.07
P/B ratio5.716.60
EV / EBITDAN/A15.76
FCF yieldN/A3.18%

Profitability

MetricKYMRPODD
Gross margin101.98%71.08%
Operating margin-891.33%16.89%
Net margin-285.41%12.29%
ROE-19.85%26.39%
ROIC-22.30%16.04%

Growth (annualized)

MetricKYMRPODD
Revenue CAGR (5Y)10.22%25.13%
EPS CAGR (5Y)N/A99.91%
Total return CAGR (5Y)12.31%-13.93%

Frequently asked

Which has grown faster, KYMR or PODD?
Over the past five years, PODD grew revenue faster — KYMR at a 10.22% CAGR versus PODD at 25.13%.
Is KYMR or PODD more profitable?
PODD runs the higher net margin — KYMR at -285.41% versus PODD at 12.29%.
How have KYMR and PODD total returns compared?
Over the past 5 years, KYMR delivered 12.31% and PODD delivered -13.93% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.